Biomedical applications of poly(lactic acid)

Recent Patents on Regenerative Medicine

Volumn 4, Issue 1, 2014, Pages 40-51

  Pawar, Rajendra P ^a   Tekale, Sunil U ^a   Shisodia, Suresh U ^a   Totre, Jalinder T ^a   Domb, Abraham J ^b  

^a DEOGIRI COLLEGE   (India)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Biomedical applications; Medical implants; PLA

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BIOMATERIAL; BIOMEDICAL AND DENTAL MATERIALS; BONE MORPHOGENETIC PROTEIN; BUPRENORPHINE; CHLORHEXIDINE; COPOLYMER; DRUG CARRIER; MACROGOL; NANOPARTICLE; PACLITAXEL; POLYGLACTIN; POLYLACTIC ACID; TISSUE SCAFFOLD; TITANIUM;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; BLADDER DISTENSION; BONE DEFECT; BONE REMODELING; COMPOSITE MATERIAL; DRUG DELIVERY SYSTEM; ENDOPROSTHESIS; FACE FRACTURE; HUMAN; HYDROGEL; LENS IMPLANT; MAXILLOFACIAL SURGERY; ORTHOPEDIC IMPLANT; OSTEOARTHRITIS; PATENT; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; SPINAL CORD INJURY; THROMBOGENICITY; TISSUE ENGINEERING; TISSUE REGENERATION; TOOTH IMPLANT; URETER STENT;

EID: 84899853971     PISSN: 22102965     EISSN: 22102973     Source Type: Journal    
DOI: 10.2174/2210296504666140402235024     Document Type: Article

References (98)

1. Kulkarni RK, Moore EG, Hegyeli AF, Leonard F. Biodegradable poly(lactic acid) polymers. J Biomed Mater Res 1971; 5: 169-81.
2. Agrawal C, Mauli, Athanasiou KA, Niederauer GG. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 17(2): 93-102.
3. Alexander H, Bajpai PK, Guastavino TD, Jenei SR. Degradation analysis of polylactic acid (PLA)-glass fiber composites. Bioengin Proc Northeast Conf 1987; 300-03.
4. Audion M, Chabot F, Christel P, Garreau H, Vert M. PGA (polyglycolic acid)-fiber-reinforced-PLA (polylactic acid) as an implant material for bone surgery. Int Conf: Composites in Bio-Med Eng 1985; 11: 1-11.
5. Zhou CR, Li LH. Application of novel PLA/chitosan composite materials on bone tissue scaffolds. Aus Soc Biomater 2004; 8: 1572.
6. Kadiyala S, Leong KW, Lo H, Ponticiello MS, Reddi AH. Bone induction achieved by controlled release of BMP from PLA/hydroxyapatite foams. Trans Annu Meet Soc Biomater Int Biomater Symp 1996; 1: 289.
7. Saikku-Baeckstroem A, Tulamo RM, Raeiha JE, Kellomaeki M, Toermaelae T, Toivonen P, et al. Intramedullary fixation of cortical bone osteotomies with absorbable self-reinforced fibrillated poly-96L/4D-lactide (SRPLA96) rods in rabbits. Biomaterials 2001; 22(1): 33-43.
8. Vaidyanathan R, Hecht B, Studley A, Phillips T, Calvert PD, Tellis B, et al. Resorbable polymer-ceramic composites for orthopedic scaffold applications. Ceramic Engin Sci Proc 2004; 25(4): 529-36.
9. Raikin SM, Ching AC. Bio absorbable fixation in foot and ankle. Foot Ankle Clin 2005; 10(4): 667-84.
10. Jadhav B, Kummer F, Lehman WB, Rohovsky MW, Strongwater A, Tunc DC. Evaluation of body absorbable bone fixation devices. Polymeric materials science and engineering, Proc. ACS Div Polym Mater 1985; 53: 502-4.
11. Nanno K, Sugiyasu K, Yoshikawa H, Myoui A, Daimon T, Myoui A. Synthetic alginate is a carrier of OP-1 for bone induction. Clin Ortho and Rel Res 2009; 467(12): 3149-55.
12. Hollinger JO. Effects of a biodegradable copolymer-proteolipid on osseous healing in rats and dogs. Trans Annu Meet Soc Biomater Int Biomater Symp 1984; 7: 5.
13. th World Biomaterials Congress, Sydney, Australia May 17-21, 2004.
14. th World Biomaterials Congress, Sydney, Australia May 17-21, 2004.
15. Lindqvist C, Suuronen R, Haers PE, Sailer HF. Update on bioresorbable plates in maxillofacial surgery. Fac Plas Surg 1999; 15(1): 61-72.
16. Eppley BL. Use of resorbable plates and screws in pediatric facial fractures. J Oral Maxillofac Surg 2005; 63(3): 385-91.
17. Ashammakhi N, Toermaelae P, Gonzalez AM, Jackson IT. New resorbable bone fixation. Biomaterials in craniomaxillo facial surgery: Present and future. Eur J Plast Surg 2004; 26(8): 383-90.
18. Cohen SR, Holmes RE, Cornwall GB, Kleinhenz KK, Thomas KA, Beckett MZ. Macro pore resorbable devices in craniofacial surgery. Clin in Plast Surg. 2004; 31(3): 393-406.
19. Peltoniemi HA, Kontio R, Salo A, Waris T, Lindqvist C, Graetz K, et al. The use of bio absorbable osteofixation devices in craniomaxillofacial surgery. Oral Surg, Oral Med, Oral Patho, Oral Radio, and Endodon 2002; 94(1): 5-14.
20. Khang G. Drug delivery system using polymers (lactide-coglycolide). IFMBE Proc IFMBE; 2013; 40: 258-61.
21. Tsuji H. Poly(lactide) stereo complexes: Formation, structure, properties, degradation, and applications. Macromolecular Bioscience 2005; 5(7): 569-97.
22. Agrawal CM, Pennick A, Schenck RC, Shen X, Szygenda DM. Protein release kinetics of a porous coated implant impregnated with a biodegradable delivery system. Trans Annu Meet Soc Biomater Int Biomater Symp 1996; 2: 151.
23. Rydholm AE, Reddy SK, Bowman CN, Anseth KS, Bowman CN, Anseth KS. Fundamental studies of degradable thiol-acrylate photopolymeric biomaterials as tissue engineering and drug delivery scaffolds. AIChE Annual Meeting, Conf Proc 2004; 89B: 6365-7.
24. Saravana KR. Chitosan microspheres as potential vaccine delivery systems. Int J Drug Del 2011; 3(1): 43-50.
25. Makarov C, Gotman I, Gutmanas EY, Radin S, Ducheyne P. Vancomycin release from bioresorbable calcium phosphate-polymer composites with high ceramic volume fractions. J Mat Sci 2010; 45(23): 6320-4.
26. Carbajal-De LT, Espinosa-Medina MA, Ibarra-Bracamontes LA, Perez-Reyes JC. Villagomez-Galindo M, Rubio-Rosas E. Synthesis of biodegradable composite for knee cartilage prosthesis joint. Mat Res Soc Sympo Proc 2011; 1376: 32-8.
27. Bajpai PK, Benghuzzi HA. Effect of molecular weight on the release of proteins from ALCAP ceramic capsules. Bioengin, Proc of the Northeast Conf 1988; 96-9.
28. Wu B, Zheng Q, Guo X, Wu Y, Wang Y, Cui F. Preparation and ectopic osteogenesis in vivo of scaffold based on mineralized recombinant human-like collagen loadedwith synthetic BMP-2-derived peptide. Biomedical Mat 2008; 3(4): 044111.
29. Barker M, Bull A, Carter A, Dootson G, Fidler E, Heskin K, et al. Development of tissue engineered meniscal cartilage implants. Annual Int Conf IEEE Engin Med and Bio-Proc 1999; 1: 111.
30. Vacanti JP, Choi RS, Kim BS, Riegler M, Pothoulakis C, Vacanti M, et al. Martin Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neo intestine. J Pedi Surg 1998; 33(7): 991-7.
31. Ginebra MP, Navarro M, Planell JA, Ambrosio L, Zeppetelli S. Development and cell response of a new biodegradable composite scaffold for guided bone regeneration. J Mat Sci: Mat in Med 2004; 15(4): 419-22.
32. Bakhru H, Bizios R, Ricci JL, Supronowicz PS. Analysis of osteoblast mineral deposits on three-dimensional, porous, polylactic acid scaffolds. Trans Annu Meet Soc Biomater Int Biomater Symp 1996; 2: 848.
33. th World Biomaterials Congress, Sydney, Australia May 17-21, 2004.
34. Efstathopoulos N, Giamarellos BEJ, Lazarettos J, Nikolaou V, Tsaganos T, Koutoukas P, et al. Elution of linezolid by a polylactic acid local antimicrobial delivery system. J Bone Joint Surg Br 2009; 91B, Supp I 129.
35. Erdohan ZO, Cam B, Turhan KN. Characterization of antimicrobial polylactic acid based films. J Food Engin 2013; 119(2): 308-15.
36. Jin T, Niemira BA. Application of polylactic acid coating with antimicrobials in reduction of Escherichia coli O157: H7 and Salmonella stanley on apples. J Food Sci 2011; 76(3): M184-8. doi: 10. 1111/j. 1750-3841. 2011. 02052. x.
37. Kyoung-Nam K, Woo-Hyun K, Sang-Bae L, Seung-Kyun M, Kwang-Mahn K, Kyoung-Nam K, et al. The release behavior of CHX from polymer-coated titanium surfaces. Surf Interf Ana 2008; 40(3-4): 202-4.
38. Araki H, Tani T, Kodama M. Antitumor effect of into polylactic acid. Artif Organs 1999; 23(2): 161-8.
39. Aikou T, Fukuzaki H, Kumanohoso T, Nakamura K, Natsugoe S, Sagara M, et al. Drug distribution and antitumor effect of bleomycin incorporated in poly DL-lactic acid in rats. Jap J Can and Chemoth 1994; 21(13): 2248-50.
40. Juha L, Antero H, Virpi T, Martti ALA-Opas, Martti T, Tero V, et al. New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: An experimental study. J Endouro 2009; 13(2): 107-12.
41. Martti A-O, Antero H, Juha L, Virpi T, Martti T, Pentti T, et al. New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: An experimental study. J Endouro 1999; 13(2): 107-12.
42. Subbarao WV. Multipurpose microcoded controllers for implanted electronic systems. Southcon Conf Record 1986; 7(2): 1-7.
43. Sasken HF, Thatcher GL, Yoklavich MF. Vessel healing response to bioabsorbable implant. Trans Annu Meet Soc Biomater Int Biomater Symp 1996; 1: 589.
44. rd International Conference on Bioinformatics and Biomedical Engineering Sydney, Australia June 11-13, 2009.
45. Prosser L, Agrawal CM, Polan J, Elliott J, Adams, DG, Bailey SR, Bailey SR. Implantation of oxygen enhanced, three-dimensional microporous L-PLA polymers: A reproducible porcine model of chronic total coronary occlusion. Catheter Cardio Interven 2006; 67(3): 412-6.
46. Alexander H, Gona AG, Parsons JR, Ricci JL. Dynamics of tendon cell growth on synthetic fiber materials in vitro. Trans Annu Meet Soc Biomater Int Biomater Symp 1984; 7: 298
47. Isele U, Matschke C, Van HP, Fahr A; Matschke. Christian sustained-release injectables formed in situ and their potential use for veterinary products. J Control Rel 2002; 85(1-3): 1-15.
48. Sambusseti, A. Improved absorbable patch, in reinforced PGA, for the replacement of a portion of bladder wall following partial cystectomy. WO2013135544 (2013).
49. Mohapatra, S., Mohapatra, S. S., Davis, Y. K., Wang, C. Threedimensional fibrous scaffolds for cell culture. US20130224860 (2013).
50. Ravis, W. R., Lin, Y.-J. Buprenorphine nanoparticle composition and methods thereof. WO2013126552 (2013).
51. Detamore, M., Berkland, C., Mohan, N., Gupta, V., Mchugh, P., Lohfeld, S. Scaffolding biomaterials based on polymer-coated high-stiffness particles. WO2013116736 (2013).
52. Marsh, D. A., Rivers, H. M. Time released biodegradable or bio erodible microspheres or micro particles suspended in a solidifying depot-forming injectable drug formulation. US20130189369 (2013).
53. Song, J., Kutikov, A. Elastomeric and degradable high-mineral content polymer composites. WO2013044078 (2013).
54. Tessmar, J., Esser, E., Bluecher, L., Milbocker, M. Composite polylactic acid/alginate surgical barrier. US20130052236 (2013).
55. Folan, M., Horgan, F., Turkington, M. Drug elution medical device. US20130018258 (2013).
56. Sung, H.-W., Liao, Z.-X., Chung, M.-F., Chen, K.-J., Tu, H. Pharmaceutical composition of nanoparticles. US8318198 (2012).
57. Sambusseti, A. Hemisphere for bladder expansion in patients with low compliance. WO2012123272 (2012).
58. Dejardin, L. Orthopedic cage. WO2012075349 (2012).
59. D'Agostino, J. A., Watterson, A. Implantable polymer for bone and vascular lesions. WO2012054742 (2012).
60. Hurtado, A., Gilbert, R. J., Wang, H. B., Cregg, J. M., Mullins, M. E., Oudega, M. Three-dimensional scaffolds, methods for fabricating the same, and methods of treating a peripheral nerve or spinal or spinal cord injury. WO2011123798 (2011).
61. Shetty, D. S., Chun, I., Vyakarmam, M. N., Hyland, T. P. Thick foams for biomedical applications and methods of making. WO2010117824 (2010).
62. Giammona, G., Pitarresi, G., Palumbo, F., Romano, C. L., Meani, E., Cremascoli, E. Antibacterial hydrogel and use thereof in orthopedics. WO2010086421 (2010).
63. Timmer, M., Yang, C., Volpe, C. G., Hammer, J. J., Shetty, D., Keeley, D. J. Donners: Biocompatible fiber based device for guided tissue regeneration. WO2010077520 (2010).
64. Rasal, R. M., Hirt, D. E. Copolymer including polylactic acid, acrylic acid and polyethylene glycol and processes for making the same. WO2010056421 (2010).
65. Downes, S., Terenghi, G., Sun, M., Kingham, P. A peripheral nerve growth scaffold which includes poly-epsilon-caprolactone (PCL). GB2463861 (2010).
66. Downes, S., Terenghi, G., Sun, M., Kingham, P. Medical device. WO2010029295 (2010).
67. Barnett, A. R., Gearhart, K. N., Lichti, J., Reyes, P. T., Sarasam, A. R. Implantable medical device coatings with biodegradable elastomer and releasable taxane agent. WO2010021757 (2010).
68. Simpson, D. G., Bowlin, G. L., Mahajan, R., Ayres, C., Bowman, J. R., Newtom, D. Methods and compositions for manipulating electro processed scaffold material properties using cross-linking and fiber tertiary structure. WO2009149181 (2009).
69. De, J. E., Reich, C. J., Boyd, S., Sierra, D., Alejandro, J. D. Corneal on lay devices and methods. WO2009146151 (2009).
70. Hammer, J. J., Shetty, D. D., Sridevi, W. Z. Optimum density fibrous matrix. US20090148495 (2009).
71. Chopra, B., McKenzie, G., Hardwick, B. Osteogenic compounds. WO2009016333 (2009).
72. McCarthy, S., Weinzweig, J. Novel biodegradable bone plates and bonding systems. US20080234754 (2008).
73. Pomahac, B. Compositions and methods for the repair and regeneration of cartilage and/or bone. WO2008086147 (2008).
74. McClain, J. B., Taylor, D., Rabiner, R. Stents having biodegradable layers. WO2008086369 (2008).
75. Robinson, M. R., Blanda, W. M., Hughes, P. M., Ruiz, G., Orilla, W. C., Whitcup, S. M. Intraocular drug delivery systems. US20080131484 (2008).
76. Cherif-Cheikh, R., De Sousa, D. A.-P., Lacombe, F., Lachamp, L., Bourissou, D. Sustained release formulations comprising very low molecular weight polymers. WO2008049631 (2008).
77. Keeley, D., Shetty, D., Dhanaraj, S., Wang, Z. Multilayered composite for organ augmentation and repair. US20080081362 (2008).
78. Gale, D. C., Hossainy, S. F. A. Method of polishing implantable medical devices to lower thrombogenecity and increase mechanical stability. US7329366 (2008).
79. Mauriac, P., Marion, P. Subcutaneous implants releasing an active principle over an extended period of time. WO2008015236 (2008).
80. Syed, F. A. H., Fuh-Wei, T., Lothar, K., Thierry, G., Yiwen, T., Wouter, R., Stephen, P., Gina, Z., Yung-Ming, C., Andrew, F. M., Sean, A. M., Brandon, J. Y. Morphology profiles for control of agent release rates from polymer matrices. WO2007146049 (2007).
81. Kaplan, S. L., Ruane, P. H., Lang, E. A., Kimura, T. Use of plasma in formation of biodegradable stent coating. US20070281117 (2007).
82. Wei, M., Olson, J. R., Shaw, M. T. Calcium phosphate polymer composite and method. US20070255422 (2007).
83. Hughes, P. M., Boix, M., Sarrazin, C., Do, M. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods. US20070224246 (2007).
84. Rizk, S., Martin, D. P., Ho, K., Ganatra, A., Williams, S. F. Toughened poly lactic acid polymers and copolymers. US20070182041 (2007).
85. Zanella, J. M., Haddock, S. M., Taylor, C. E., Kitching, K. J. Modification of chemical forces of bone constructs. US20070173950 (2007).
86. Dave, V. B. Bio absorbable drug delivery devices. US20070162110 (2007).
87. Hunt, M. M., Hooper, D., Meunier, A., Jara-Alamonte, J. Improved method of treating degenerative spinal disorders. WO2006138690 (2006).
88. Pacetti, S. D., Hossainy, S. F. A, Gale, D. C. Amorphous poly(D, Llactide) coating. US20060246108 (2006).
89. Furst, J. G., Brodbeck, W. G. Polymer biodegradable medical device. US20060193892 (2006).
90. Siegel, S., Winey, K. Drug-containing implants and methods of use thereof. US20060159721 (2006).
91. Ghabrial, R., Fung, R., Rezania, A., Davis, J. E. Multi-compartment delivery system. US20060153894 (2006).
92. Pastorello, A., Ambrosio, L., Tafuri, G., Pavesio, A. A biocompatible material and a prosthetic device made thereof for the replacement, repair and regeneration of meniscus. WO2006064025 (2006).
93. Mao, J. Hollow and porous orthopedic or dental implant that delivers a biological agent. WO2006047310 (2006).
94. Bloemer, W., Beger, J., Fink, U., Wagner, C. Implant for insertion into a bone cavity or between vertebral bodies. US20060009844 (2006).
95. Malaviya, P., Orban, J. M., Jenks, P. J., Whalen, T. Hybrid biologicsynthetic bio absorbable scaffolds. EP1593400 (2005).
96. Hughes, P. M., Malone, T. C., De Vries, G. W., Edelman, J. L., Chang-Lin, J.-. E., Shiah, J. G., Nivaggioli, T. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods. US20050244470 (2005).
97. Ringeisen, T. A., Turner, A., Demeo, J., Hearn, P. E., McDade, R. L. Compressed porous materials suitable for implant. US20050246021 (2005).
98. Dissolvable stents from Abbott laboratories. http://gizfactory. com/article/dissolvable-stents-from-abbottlaboratories (Accessed on: April 3, 2014).